PUBLISHER: The Business Research Company | PRODUCT CODE: 1833952
PUBLISHER: The Business Research Company | PRODUCT CODE: 1833952
Automated nucleic acid extraction devices are laboratory instruments designed to isolate DNA (deoxyribonucleic acid) or RNA (ribonucleic acid) from biological samples using automated processes. These devices perform lysis, binding, washing, and elution steps with minimal human intervention, often using magnetic beads or spin column technologies. The primary purpose of automated nucleic acid extraction devices is to streamline and standardize the extraction process, ensuring high yield, purity, and reproducibility of nucleic acids for downstream applications such as polymerase chain reaction (PCR), sequencing, and diagnostics.
The automated nucleic acid extraction devices market consists of sales, by entities (organizations, sole traders and partnerships), of automated nucleic acid extraction devices are used across clinical diagnostics, research, forensic analysis, pharmaceutical development and public health surveillance.
The global automated nucleic acid extraction devices market was valued at $3,356.24 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 12.00%.
Rising R&D Spending in Life Sciences
Rising research and development (R&D) spending in life sciences fueled the growth of the automated nucleic acid extraction devices in the historic period. Increasing R&D spending in the life sciences boosts the demand for automated nucleic acid extraction devices by supporting more large-scale molecular biology, genomics, and biotechnology projects. With greater funding, research institutions and biopharma companies are investing in high-throughput, automated solutions to improve efficiency and reproducibility in sample preparation. These devices streamline workflows, reduce manual labor, and enable faster discovery and development processes. As R&D budgets grow, so does the adoption of advanced automation technologies, including nucleic acid extraction systems. For instance, in July 2024, according to the GOV.UK, a UK-based government department, in 2022, the business enterprise sector conducted £9.0 billion ($11.7 billion) in pharmaceutical R&D, representing 0.36% of the UK's GDP. Pharmaceutical R&D made up 18% of all R&D carried out by businesses in the UK, the highest percentage among all product areas. Therefore, the rising R&D spending in life sciences drove the growth of the automated nucleic acid extraction devices market.
Focus on Advancing Fully Automated, Maxi-Scale DNA Purification Technologies
Companies operating in the automated nucleic acid extraction devices market are focusing on developing fully automated, maxi-scale purification systems that eliminate manual steps such as setup, centrifugation and pipetting. These innovations use self-contained cartridges with preloaded reagents to simplify workflows, reduce contamination risks and accelerate the production of high-purity plasmid DNA for advanced therapeutics. For instance, in June 2024, Thermo Fisher Scientific, a US-based biotechnology company specializing in scientific instrumentation, reagents, and laboratory services, introduced the Thermo Scientific KingFisher PlasmidPro Maxi Processor (PlasmidPro), the only fully automated maxi-scale plasmid DNA purification system aimed at accelerating therapeutic discovery and development. This advanced system enables fully automated processing from culture to purified plasmid DNA without any manual steps such as setup, centrifugation or pipetting, using a self-contained cartridge preloaded with all required reagents. Designed to handle 100-150 mL of overnight culture and deliver up to 1.5 mg of high-purity plasmid DNA in about 75 minutes, PlasmidPro simplifies workflows, minimizes contamination risk and supports the rapid progress of cell and gene therapies, monoclonal antibody development, mRNA-based treatments and vaccines amid increasing global clinical trial activity.
The global automated nucleic acid extraction devices market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 31.55% of the total market in 2024.
Automated Nucleic Acid Extraction Devices Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global automated nucleic acid extraction devices market as it emerges from the COVID-19 shut down.
Where is the largest and fastest-growing market for automated nucleic acid extraction devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The automated nucleic acid extraction devices market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider automated nucleic acid extraction devices market; and compares it with other markets.